Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

20011,185 citationsJournal Articlebronze Open Access

Authors

Gilles Montalescot · Sorbonne Université

Paul Barragan · Hôpital Privé Marseille Beauregard

Olivier Wittenberg

Patrick Ecollan · Pitié-Salpêtrière Hospital

Simon Elhadad · Institution de Lavigny

P Villain

Jean-Marc Boulenc · Saint Joseph Hospital

Marie‐Claude Morice

Abstract

As compared with placebo, early administration of abciximab in patients with acute myocardial infarction improves coronary patency before stenting, the success rate of the stenting procedure, the rate of coronary patency at six months, left ventricular function, and clinical outcomes.

Topics & Keywords

Acute Myocardial Infarction Research Coronary Interventions and Diagnostics Cardiac Valve Diseases and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 344, Issue 25, pp. 1895-1903

DOI: 10.1056/nejm200106213442503

Field-Weighted Citation Impact: 62.40